Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressConvertible DebtCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Long Term Debt
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mainz Biomed N.V (MYNZ) Payables: 2020-2024

Historic Payables for Mainz Biomed N.V (MYNZ) over the last 5 years, with Dec 2024 value amounting to $1.3 million.

  • Mainz Biomed N.V's Payables fell 63.89% to $596,886 in Q2 2025 from the same period last year, while for Jun 2025 it was $6.7 million, marking a year-over-year decrease of 26.38%. This contributed to the annual value of $1.3 million for FY2024, which is 60.61% down from last year.
  • Latest data reveals that Mainz Biomed N.V reported Payables of $1.3 million as of FY2024, which was down 60.61% from $3.2 million recorded in FY2023.
  • Over the past 5 years, Mainz Biomed N.V's Payables peaked at $3.2 million during FY2023, and registered a low of $423,664 during FY2020.
  • Moreover, its 3-year median value for Payables was $2.7 million (2022), whereas its average is $2.4 million.
  • Per our database at Business Quant, Mainz Biomed N.V's Payables skyrocketed by 252.65% in 2022 and then crashed by 60.61% in 2024.
  • Mainz Biomed N.V's Payables (Yearly) stood at $423,664 in 2020, then surged by 81.87% to $770,522 in 2021, then soared by 252.65% to $2.7 million in 2022, then climbed by 17.19% to $3.2 million in 2023, then slumped by 60.61% to $1.3 million in 2024.